characteristic | Baseline | After 12 week | P a | Change (%) | P b |
---|---|---|---|---|---|
hs-CRP (ng/dL) | |||||
Curcumin group | 5647.1 ± 3858.4 | 4653.8 ± 4243.8 | 0.12 | − 993.3 ± 385.4 | 0.660 |
Placebo group | 6705.0 ± 4794.9 | 5310.2 ± 5071.7 | 0.53 | − 1394.8 ± 276.8 | |
TNF-α (pg/mL) | |||||
Curcumin group | 19.34 ± 5.4 | 16.51 ± 4.5 | < 0.001 | −2.83 ± 0.9 | 0.972 |
Placebo group | 18.63 ± 2.2 | 16.54 ± 2.1 | 0.02 | −2.09 ± 0.1 | |
NF-κB | |||||
Curcumin group | 2.07 ± 1.03 | 1.65 ± 0.63 | 0.044 | −0.49 ± 0.29 | 0.539 |
Placebo group | 2.13 ± 0.92 | 2.03 ± 0.51 | 0.209 | − 0.26 ± 0.20 | |
ALT (IU/L) | |||||
Curcumin group | 26.54 ± 15.46 | 20.82 ± 10.09 | < 0.001 | −5.58 ± 14.6 | 0.778 |
Placebo group | 28.02 ± 13.06 | 21.2 ± 7.72 | < 0.001 | −6.82 ± 15.8 | |
AST (IU/L) | |||||
Curcumin group | 17.78 ± 9.56 | 14.75 ± 7.45 | < 0.001 | −2.76 ± 7.54 | 0.728 |
Placebo group | 16.23 ± 5.66 | 12.77 ± 4.05 | < 0.001 | −3.46 ± 5.43 | |
Fibrosis (kPa) | |||||
Curcumin group | 6.98 ± 2.42 | 6.2 ± 2.38 | < 0.001 | −0.78 ± 0.89 | 0.364 |
Placebo group | 6.52 ± 2.38 | 6.02 ± 1.8 | 0.095 | −0.49 ± 1.15 | |
Steatosis (db/m) | |||||
Curcumin group | 298.35 ± 29.5 | 282.65 ± 40.09 | 0.015 | −15.69 ± 30.72 | 0.112 |
Placebo group | 315.18 ± 35.69 | 283.18 ± 49.83 | 0.001 | −32 ± 34.3 |